GSA Capital Partners LLP Acquires Shares of 171,280 Neogen Corporation $NEOG

GSA Capital Partners LLP acquired a new stake in shares of Neogen Corporation (NASDAQ:NEOG) in the 4th quarter, Holdings Channel.com reports. The fund acquired 171,280 shares of the company’s stock, valued at approximately $1,197,000.

Other institutional investors have also recently made changes to their positions in the company. ING Groep NV bought a new position in shares of Neogen in the 3rd quarter valued at about $80,288,000. IQ EQ FUND MANAGEMENT IRELAND Ltd lifted its holdings in shares of Neogen by 84.9% in the 3rd quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 351,155 shares of the company’s stock valued at $2,005,000 after acquiring an additional 161,241 shares during the last quarter. Public Sector Pension Investment Board lifted its holdings in shares of Neogen by 26.0% in the 3rd quarter. Public Sector Pension Investment Board now owns 847,266 shares of the company’s stock valued at $4,838,000 after acquiring an additional 174,962 shares during the last quarter. Hudson Bay Capital Management LP bought a new position in shares of Neogen in the 3rd quarter valued at about $28,550,000. Finally, CIBC Bancorp USA Inc. bought a new position in shares of Neogen in the 3rd quarter valued at about $28,969,000. Institutional investors own 96.73% of the company’s stock.

Neogen Stock Performance

Neogen stock opened at $8.83 on Thursday. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.92 and a quick ratio of 2.84. Neogen Corporation has a 1-year low of $4.53 and a 1-year high of $11.43. The firm has a market capitalization of $1.92 billion, a P/E ratio of -3.15, a price-to-earnings-growth ratio of 3.63 and a beta of 1.84. The company’s 50-day moving average is $9.19 and its 200 day moving average is $8.63.

Neogen (NASDAQ:NEOG) last posted its quarterly earnings data on Thursday, April 9th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.05. Neogen had a negative net margin of 69.93% and a positive return on equity of 2.35%. The company had revenue of $211.20 million for the quarter, compared to analyst estimates of $204.62 million. The firm’s revenue for the quarter was down 4.4% compared to the same quarter last year. Research analysts forecast that Neogen Corporation will post 0.23 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on NEOG shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Neogen in a report on Friday, April 10th. William Blair reaffirmed a “market perform” rating on shares of Neogen in a report on Monday, March 2nd. Finally, Wall Street Zen raised shares of Neogen from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $10.67.

Neogen Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user?friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.